REPLAY: WORLD ORGANOID RESEARCH DAY+ 2024
UPM Biomedicals

Where: 17
UPM Biomedicals is the forerunner in producing high quality nanofibrillar cellulose for medical and life science applications. More than 300 patents protect the existing and future products that rely on the Finnish birch pulp. We actively collaborate with universities, research centers and key industrial partners on future innovations and products in the field of high throughput drug screening, personalized medicine, advanced cell therapies, 3D bioprinting, tissue engineering and advanced wound care.

We are part of UPM, the Biofore Company that creates value from renewable and recyclable materials. In 2022, UPM’s sales were approximately EUR 11.7 billion. UPM has production plants in 12 countries and a global sales network. UPM employs approximately 17,200 employees worldwide. UPM shares are listed on the NASDAQ OMX Helsinki stock exchange. At the end of 2022, UPM had approximately 132,100 shareholders.
Tel: +44 (0) 7484 511878
Address: UPM Biomedicals | Biomedicum 2U, Tukholmankatu 8 | 00290 Helsinki, FINLAND
Website: https://www.upmbiomedicals.com/
Email: steven.worrall@upm.com

Talks at REPLAY: WORLD ORGANOID RESEARCH DAY+ 2024

Sat1  Jun12:20pm(5 mins)
Room: Conference Hall

Staff Attending

Dr Jonathan Sheard
Application Scientist
UPM Biomedicals
Finland
Mr Steven Worrall
Sales Manager - Life Sciences
UPM Biomedicals

Find out more...

To view the virtial stand - please login first

LinkedIn URL